Published by Iain Gilbert on 15th October 2018
(Sharecast News) - Biopharmaceutical group Hemogenyx has entered into a collaboration agreement industry giant Johnson and Johnson to develop a model of systemic lupus erythematosus, the most common form of Lupus.
URL: http://www.digitallook.com/dl/news/story/28135508/...